Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer

Completed · Not applicable

Conditions studied: Lung Cancer

In brief

The purpose of this study is to evaluate the efficacy and toxicity stereotactic body radiation (SBRT) as consolidation following standard chemoradiation for patients with stage III non-small cell lung cancer.

Key facts

Study ID

NCT01656460

Run by

Dr Thomas DiPetrillo

People needed

12

Starts

2012-04-01

Expected to finish

2017-05-16

Last updated by the study team

2020-07-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• memorial Hospital of Rhode island — Pawtucket, Rhode Island, United States
• Rhode Island Hospital — Providence, Rhode Island, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.